Retacrit and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Retacrit (epoetin alfa-epbx), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Jakafi, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Joint pain when taking Retacrit. It is created by eHealthMe based on reports of 2,195 people who have side effects when taking Retacrit from the FDA, and is updated regularly.

What is Retacrit?

Retacrit has active ingredients of epoetin alfa-epbx. eHealthMe is studying from 2,196 Retacrit users. Check the latest studies of Retacrit.

What is Joint pain?

Joint pain is found to be associated with 3,329 drugs and 5,209 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 27, 2026

2,195 people reported to have side effects when taking Retacrit.
Among them, 23 people (1.05%) have Joint pain.

Among these 23 people:

How long have people been on Retacrit when they have Joint pain? *

What is the gender of people who have Joint pain when taking Retacrit? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Joint pain when taking Retacrit? *

What are other drugs people take besides Retacrit? *

What are other side effects people have besides Joint pain? *

Fatigue (feeling of tiredness): 15 people, 65.22%
Weakness: 15 people, 65.22%
Haemoglobin Decreased: 13 people, 56.52%
Back Pain: 13 people, 56.52%
Stress And Anxiety: 12 people, 52.17%
Pain In Extremity: 12 people, 52.17%
Thrombocytopenia (decrease of platelets in blood): 11 people, 47.83%
Depression: 10 people, 43.48%
Urinary Tract Infection: 10 people, 43.48%
Muscle Spasms (muscle contraction): 10 people, 43.48%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 12 people, 52.17%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 11 people, 47.83%
Anaemia (lack of blood): 3 people, 13.04%
Blood Erythropoietin Decreased: 2 people, 8.70%
Blood Pressure Abnormal: 2 people, 8.70%
Pain: 2 people, 8.70%
Neuropathy Peripheral (surface nerve damage): 2 people, 8.70%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 8.70%
Stress And Anxiety: 2 people, 8.70%
Type 1 Diabetes: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Retacrit and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Retacrit:

Retacrit (2,196 reports)

Joint pain treatments and more:

Joint pain (542,935 reports)

Browse all side effects of Retacrit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,329 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,209 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on epoetin alfa-epbx (the active ingredients of Retacrit) and Retacrit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.